RGH-1756, a new potential atypical antipsychotic: Receptor profile and effect on prolactin secretion

被引：0
|
作者：
Laszlovszky, I [1 ]
Csejtei, M [1 ]
Lapis, E [1 ]
机构：
[1] Gedeon Richter Ltd, Pharmacol Res Ctr, H-1475 Budapest 10, Hungary
来源：
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY | 1998年 / 358卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
P35123
引用
收藏
页码：R58 / R58
页数：1
相关论文
共 50 条
  • [31] THE EFFECT OF DOPAMINE RECEPTOR AGONISTS ON PROLACTIN SECRETION IN CHILDHOOD MIGRAINE
    DANDREA, G
    CANANZI, AR
    GRIGOLETTO, F
    MENEGHINI, F
    CORTESI, S
    SOFFIATI, G
    JOSEPH, R
    NORDERA, G
    FERROMILONE, F
    HEADACHE, 1988, 28 (05): : 354 - 359
  • [32] MUSCARINIC RECEPTOR BLOCKADE BY PIRENZEPINE - EFFECT ON PROLACTIN SECRETION IN MAN
    MASALA, A
    ALAGNA, S
    DEVILLA, L
    ROVASIO, PP
    RASSU, S
    FAEDDA, R
    SATTA, A
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 1982, 5 (01) : 53 - 55
  • [33] Pharmacokinetic profile and clinical efficacy of long-acting risperidone: Potential benefits of combining an atypical antipsychotic and a new delivery system
    Ereshefsky L.
    Mannaert E.
    Drugs in R & D, 2005, 6 (3) : 129 - 137
  • [34] The synthesis and receptor binding affinities of DDD-016, a novel, potential, atypical antipsychotic
    Bandyopadhyaya, Achintya
    Rajagopalan, Desikan R.
    Rath, Nigam P.
    Herrold, Amy
    Rajagopalan, Raghavan
    Napier, T. Celesete
    Tedford, Clark E.
    Rajagopalan, Parthasarathi
    MEDCHEMCOMM, 2012, 3 (05) : 580 - 583
  • [35] Extended-release paliperidone: Efficacy, safety and tolerability profile of a new atypical antipsychotic
    Owen, Richard T.
    DRUGS OF TODAY, 2007, 43 (04) : 249 - 258
  • [36] Neuropharmacological profile of EMD 57445, a sigma receptor ligand with potential antipsychotic activity
    Maj, J
    Rogoz, Z
    Skuza, G
    Mazela, H
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1996, 315 (03) : 235 - 243
  • [37] PROLACTIN SECRETION, A MEASURABLE CENTRAL EFFECT OF OPIATE-RECEPTOR ANTAGONISTS
    GOLD, MS
    REDMOND, DE
    DONABEDIAN, RK
    LANCET, 1978, 1 (8059): : 323 - 324
  • [38] Participation of membrane progesterone receptor α in the inhibitory effect of progesterone on prolactin secretion
    Camilletti, M. A.
    Ferraris, J.
    Abeledo-Machado, A.
    Converse, A.
    Faraoni, E. Y.
    Pisera, D.
    Gutierrez, S.
    Thomas, P.
    Diaz-Torga, G.
    JOURNAL OF NEUROENDOCRINOLOGY, 2018, 30 (09)
  • [39] Neurotensin receptor antagonist SR 142948A alters Fos expression and extrapyramidal side effect profile of typical and atypical antipsychotic drugs
    Binder, EB
    Kinkead, B
    Owens, MJ
    Nemeroff, CB
    NEUROPSYCHOPHARMACOLOGY, 2004, 29 (12) : 2200 - 2207
  • [40] Neurotensin Receptor Antagonist SR 142948A Alters Fos Expression and Extrapyramidal Side Effect Profile of Typical and Atypical Antipsychotic Drugs
    Elisabeth B Binder
    Becky Kinkead
    Michael J Owens
    Charles B Nemeroff
    Neuropsychopharmacology, 2004, 29 : 2200 - 2207
12345